Subtopic Deep Dive
Pediatric Chylothorax
Research Guide
What is Pediatric Chylothorax?
Pediatric chylothorax is the accumulation of chyle in the pleural space in children, often due to congenital lymphatic malformations or postoperative complications following cardiac surgery.
It commonly occurs in neonates after congenital heart surgery with reported incidence rates analyzed in multi-institution databases (Mery et al., 2013, 164 citations). Conservative treatments like medium-chain triglyceride (MCT) diets show efficacy in infants (Biewer et al., 2010, 118 citations). Somatostatin therapy resolves persistent cases postoperatively (Rimensberger et al., 1998, 201 citations). Over 10 key papers from 1996-2017 address incidence, risk factors, and management.
Why It Matters
Pediatric chylothorax leads to high morbidity from malnutrition and respiratory failure due to immature lymphatic systems, with Mery et al. (2013) reporting incidence and treatments from a large database of cardiac surgery cases. Post-surgical cases after congenital heart disease repair require rapid intervention, as Biewer et al. (2010) identified risk factors and MCT-diet efficacy in newborns. Rimensberger et al. (1998) demonstrated somatostatin's role in persistent cases, reducing hospitalization and improving survival predictors in clinical practice.
Key Research Challenges
Postoperative Incidence Variability
Chylothorax incidence after pediatric cardiac surgery varies widely, complicating risk prediction. Mery et al. (2013) analyzed a multi-institution database showing rates dependent on surgical complexity. Standardization of diagnostic criteria remains needed for consistent reporting.
Optimal Conservative Therapy Duration
Balancing MCT-diet and somatostatin therapy duration against nutritional risks challenges management. Biewer et al. (2010) reported MCT-diet efficacy but variable resolution times in infants. Rimensberger et al. (1998) showed somatostatin success in persistent cases, yet optimal protocols lack consensus.
Lymphatic Intervention Safety
Percutaneous embolization for abnormal pulmonary lymphatic flow risks in congenital heart patients. Dori et al. (2016) treated plastic bronchitis cases linked to chylothorax, demonstrating feasibility. Long-term efficacy and complication rates in pediatrics require further validation.
Essential Papers
Percutaneous Lymphatic Embolization of Abnormal Pulmonary Lymphatic Flow as Treatment of Plastic Bronchitis in Patients With Congenital Heart Disease
Yoav Dori, Marc S. Keller, Jonathan J. Rome et al. · 2016 · Circulation · 287 citations
Background— Plastic bronchitis is a potentially fatal disorder occurring in children with single-ventricle physiology, and other diseases, as well, such as asthma. In this study, we report findings...
A review of the postoperative lymphatic leakage
Shulan Lv, Qing Wang, Wanqiu Zhao et al. · 2017 · Oncotarget · 217 citations
Lymphatic complications are rare, but well-known phenomena, and have been described by many researchers. However, many diagnoses of lymphatic complications are found confusing due to different defi...
Treatment of a persistent postoperative chylothorax with somatostatin
Peter C. Rimensberger, Beatrice Müller-Schenker, Afksendiyos Kalangos et al. · 1998 · The Annals of Thoracic Surgery · 201 citations
Clinical practice
Marjet J.A.M. Braamskamp, Koert M. Dolman, Merit M. Tabbers · 2010 · European Journal of Pediatrics · 170 citations
Protein-losing enteropathy (PLE) is a rare complication of a variety of intestinal disorders characterized by an excessive loss of proteins into the gastrointestinal tract due to impaired integrity...
Chylous Ascites: Evaluation and Management
Said A. Al‐Busafi, Peter Ghali, Marc Deschênes et al. · 2014 · ISRN Hepatology · 166 citations
Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, abdominal ...
Incidence and treatment of chylothorax after cardiac surgery in children: Analysis of a large multi-institution database
Carlos M. Mery, Brady S. Moffett, Muhammad Shoaib Khan et al. · 2013 · Journal of Thoracic and Cardiovascular Surgery · 164 citations
Abdominal cystic lymphangioma in children: Benign lesions that can have a proliferative course
Henri Steyaert, Jacques Guitard, J. Moscovici et al. · 1996 · Journal of Pediatric Surgery · 162 citations
Reading Guide
Foundational Papers
Start with Rimensberger et al. (1998, 201 citations) for somatostatin therapy basics, then Mery et al. (2013, 164 citations) for incidence data from large databases, and Biewer et al. (2010, 118 citations) for MCT-diet protocols in infants.
Recent Advances
Study Dori et al. (2016, 287 citations) for percutaneous lymphatic embolization in congenital heart cases; Lv et al. (2017, 217 citations) reviews postoperative leakage management.
Core Methods
Core techniques: conservative (MCT-diet, somatostatin per Rimensberger 1998, Biewer 2010); interventional (lymphatic embolization, Dori 2016); diagnostic via multi-institution database analysis (Mery 2013).
How PapersFlow Helps You Research Pediatric Chylothorax
Discover & Search
Research Agent uses searchPapers and citationGraph to map pediatric chylothorax literature from Mery et al. (2013) central node, revealing 164 citations on post-cardiac surgery incidence. exaSearch uncovers related lymphatic flow studies like Dori et al. (2016); findSimilarPapers extends to Biewer et al. (2010) for MCT-diet efficacy.
Analyze & Verify
Analysis Agent applies readPaperContent to extract incidence rates from Mery et al. (2013), then runPythonAnalysis with pandas to compute survival predictors across datasets. verifyResponse (CoVe) cross-checks somatostatin efficacy claims from Rimensberger et al. (1998) against Biewer et al. (2010), with GRADE grading for evidence quality in conservative therapies.
Synthesize & Write
Synthesis Agent detects gaps in lymphatic intervention trials post-Dori et al. (2016), flags contradictions in MCT-diet durations between Biewer et al. (2010) and Mery et al. (2013). Writing Agent uses latexEditText, latexSyncCitations for Mery et al., and latexCompile to generate review manuscripts; exportMermaid visualizes treatment flowcharts.
Use Cases
"Analyze chylothorax incidence rates and survival predictors from multi-center pediatric cardiac surgery data"
Research Agent → searchPapers('pediatric chylothorax cardiac surgery') → Analysis Agent → readPaperContent(Mery et al. 2013) → runPythonAnalysis(pandas aggregation of rates) → GRADE-graded statistical summary with confidence intervals.
"Draft a review on somatostatin vs MCT-diet for postoperative pediatric chylothorax"
Synthesis Agent → gap detection(Rimensberger 1998, Biewer 2010) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(all refs) → latexCompile → PDF with embedded treatment algorithm via exportMermaid.
"Find code for lymphatic flow modeling in congenital heart disease chylothorax cases"
Research Agent → citationGraph(Dori 2016) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python scripts for embolization simulation, verified via runPythonAnalysis.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ chylothorax papers: searchPapers → citationGraph(Mery 2013 hub) → structured report on incidence/treatments. DeepScan applies 7-step analysis with CoVe checkpoints to validate MCT-diet efficacy from Biewer et al. (2010). Theorizer generates hypotheses on lymphatic predictors from Dori et al. (2016) embolization data.
Frequently Asked Questions
What defines pediatric chylothorax?
Pediatric chylothorax is chyle accumulation in the pleural space, primarily post-cardiac surgery or from congenital malformations (Mery et al., 2013).
What are key management methods?
Conservative approaches include MCT-diet (Biewer et al., 2010) and somatostatin infusion (Rimensberger et al., 1998); interventional options involve lymphatic embolization (Dori et al., 2016).
Which papers have highest citations?
Rimensberger et al. (1998, 201 citations) on somatostatin; Mery et al. (2013, 164 citations) on incidence post-surgery; Dori et al. (2016, 287 citations) on embolization.
What open problems exist?
Challenges include standardizing therapy durations, predicting incidence by surgical type (Mery et al., 2013), and long-term outcomes of percutaneous interventions (Dori et al., 2016).
Research Lymphatic Disorders and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pediatric Chylothorax with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers